Vigabatrin-13C-d2 (hydrochloride)
|
- $169 - $590
- Product name: Vigabatrin-13C-d2 (hydrochloride)
- CAS: 2749628-08-6
- MF: C5(13C)H10D2ClNO2
- MW: 168.62
- EINECS:
- MDL Number:
- Synonyms:Vigabatrin-13C-d2 (hydrochloride)
4 prices
Selected condition：
Brand
- aablocks
- Cayman Chemical
- Medical Isotopes, Inc.
Package
- 500μg
- 1mg
- Manufactureraablocks
- Product numberAA01XHPJ
- Product descriptionVigabatrin-13C-d2 (hydrochloride) ≥99%deuteratedforms(d1-d2)
- Packaging1mg
- Price$303
- Updated2026-06-01
- Buy
- ManufacturerCayman Chemical
- Product number26672
- Product descriptionVigabatrin-13C-d2 (hydrochloride) ≥99%deuteratedforms(d1-d2)
- Packaging500μg
- Price$169
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number26672
- Product descriptionVigabatrin-13C-d2 (hydrochloride) ≥99%deuteratedforms(d1-d2)
- Packaging1mg
- Price$303
- Updated2026-04-30
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product numberCD75226
- Product descriptionVigabatrin-13C,d2hydrochloride
- Packaging1mg
- Price$590
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01XHPJ | Vigabatrin-13C-d2 (hydrochloride) ≥99%deuteratedforms(d1-d2) | 1mg | $303 | 2026-06-01 | Buy |
| Cayman Chemical | 26672 | Vigabatrin-13C-d2 (hydrochloride) ≥99%deuteratedforms(d1-d2) | 500μg | $169 | 2026-04-30 | Buy |
| Cayman Chemical | 26672 | Vigabatrin-13C-d2 (hydrochloride) ≥99%deuteratedforms(d1-d2) | 1mg | $303 | 2026-04-30 | Buy |
| Medical Isotopes, Inc. | CD75226 | Vigabatrin-13C,d2hydrochloride | 1mg | $590 | 2021-12-16 | Buy |
Properties
solubility :Water: soluble
Safety Information
| Symbol(GHS): |
|
|||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Vigabatrin-13C-d2 is intended for use as an internal standard for the quantification of vigabatrin (Item No. 9000976) by GC- or LC-MS. Vigabatrin is an irreversible GABA transaminase (GABA-T) inhibitor.1 It inhibits rat brain GABA-T when used at a concentration of 0.1 mM. Vigabatrin is selective for rat brain GABA-T over P. fluorescens GABA-T at 10 mM and is 100-fold selective over glutamic acid decarboxylase (GAD). Vigabatrin (1,500 mg/kg) decreases brain GABA-T activity without affecting GAD activity in mice.2 It reduces the incidence of myoclonus in a mouse model of audiogenic seizures.3 Vigabatrin also increases the electroconvulsive threshold in mouse model of maximal electroshock-induced seizures and reduces the number of clonic convulsions induced by pentylenetetrazol (PTZ; Item No. 18682) in mice.4 Formulations containing vigabatrin have been used in the treatment of seizures and infantile spasms.WARNING This product is not for human or veterinary use.Related product price
-
Saxagliptin-13C-d2 (hydrochloride)
$440-1714 -
FK-506-13C-d2
$520-6470.73